Quick navigation menu :
  1. Go to content
  2. Go to the main sections menu
  3. Go to the subsections menu
  4. Go to the search engine
  5. Go to the languages menu
  6. Go to the help menu
  7. Go to the slots
  8. Go to contact slot
You are here:
  1. Home
  2. > Investors
  3. > Corporate governance
Languages menu :
 

Contacts

Investor Relations only
Tel (33) 1 53 77 45 45

USA Tel +1 908 981 5560
For other inquiries:
Please click on this link
Individual Shareholders only
Free n°
(33) 800 07 58 76

USA free n°
+1 888 516 3002
For other inquiries:
Please click on this link
Address
174, avenue de France
75013 PARIS
FRANCE
Switchboard:
(33) 1 53 77 40 00
Content :

Our Corporate Governance

Adapting the rules of corporate governance to ensure transparency and shareholder information

Jean-François Dehecq, aged 67
Chairman
As of January 1st, 2007
Term of office ends: 2008
Gérard Le Fur, aged 56
Chief Executive Officer
As of January 1st, 2007
Term of office ends: 2010
Director
Date appointed: May 2006
Term of office ends: 2010

The Board of Directors

Subject to the authority expressly reserved by law to the General Meetings of shareholders, and within the scope of the corporate objects, the Board of Directors deals with and takes decisions upon issues relating to the proper management of the company and other matters concerning the Board.

The composition and responsibilities of the Committees are described in the "Board of Directors" section.

Specialist Committees

In 1999, the Board of Directors set up Specialist Committees charged with providing input to assist the Board in its decision- making. Members of these committees are chosen by the Board from amongst its members on the strength of their experience. Each committee is chaired by an independent director.

The composition and responsibilities of the Committees are described in the "Specialist Committees" section.

© sanofi-aventis 2004-2008 | Legal notice | Update: March 17, 2008